No­vavax to pro­vide 1.5M more Covid vac­cine dos­es to the US gov­ern­ment

No­vavax will still be man­u­fac­tur­ing Covid vac­cine dos­es for the US gov­ern­ment.

On Mon­day, the Mary­land-based vac­cine mak­er an­nounced that, in col­lab­o­ra­tion with HHS and DoD, it plans to de­liv­er up to 1.5 mil­lion dos­es of its Covid-19 vac­cine. The agree­ment will al­low for ac­cess to No­vavax’s Covid vac­cine and help with de­vel­op­ing oth­er dosages for dif­fer­ent strains of the virus, ac­cord­ing to a re­lease from No­vavax.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA